全文获取类型
收费全文 | 19229篇 |
免费 | 1359篇 |
国内免费 | 71篇 |
专业分类
耳鼻咽喉 | 342篇 |
儿科学 | 516篇 |
妇产科学 | 341篇 |
基础医学 | 2280篇 |
口腔科学 | 243篇 |
临床医学 | 1933篇 |
内科学 | 4360篇 |
皮肤病学 | 468篇 |
神经病学 | 1671篇 |
特种医学 | 676篇 |
外科学 | 2865篇 |
综合类 | 229篇 |
现状与发展 | 1篇 |
一般理论 | 18篇 |
预防医学 | 1755篇 |
眼科学 | 498篇 |
药学 | 1254篇 |
中国医学 | 25篇 |
肿瘤学 | 1184篇 |
出版年
2023年 | 95篇 |
2022年 | 164篇 |
2021年 | 444篇 |
2020年 | 270篇 |
2019年 | 414篇 |
2018年 | 529篇 |
2017年 | 357篇 |
2016年 | 419篇 |
2015年 | 463篇 |
2014年 | 674篇 |
2013年 | 944篇 |
2012年 | 1368篇 |
2011年 | 1445篇 |
2010年 | 793篇 |
2009年 | 749篇 |
2008年 | 1213篇 |
2007年 | 1318篇 |
2006年 | 1274篇 |
2005年 | 1247篇 |
2004年 | 1252篇 |
2003年 | 1088篇 |
2002年 | 958篇 |
2001年 | 175篇 |
2000年 | 158篇 |
1999年 | 197篇 |
1998年 | 244篇 |
1997年 | 167篇 |
1996年 | 143篇 |
1995年 | 144篇 |
1994年 | 130篇 |
1993年 | 112篇 |
1992年 | 111篇 |
1991年 | 93篇 |
1990年 | 70篇 |
1989年 | 86篇 |
1988年 | 77篇 |
1987年 | 78篇 |
1986年 | 81篇 |
1985年 | 84篇 |
1984年 | 89篇 |
1983年 | 66篇 |
1982年 | 93篇 |
1981年 | 100篇 |
1980年 | 84篇 |
1979年 | 71篇 |
1978年 | 56篇 |
1977年 | 72篇 |
1976年 | 44篇 |
1975年 | 44篇 |
1974年 | 45篇 |
排序方式: 共有10000条查询结果,搜索用时 208 毫秒
51.
52.
Identification of the protein encoded by the human diffuse B-cell lymphoma (dbl) oncogene. 总被引:1,自引:0,他引:1
下载免费PDF全文
![点击此处可从《Proceedings of the National Academy of Sciences of the United States of America》网站下载免费的PDF全文](/ch/ext_images/free.gif)
S K Srivastava R H Wheelock S A Aaronson A Eva 《Proceedings of the National Academy of Sciences of the United States of America》1986,83(23):8868-8872
The dbl oncogene was initially isolated from a human diffuse B-cell lymphoma. Antisera from mice bearing tumors induced by this oncogene specifically detected a protein of about 66 kDa (p66) in dbl transformants. dbl cDNA-selected poly(A)+ RNA isolated from a transfectant clone expressing p66 directed the in vitro synthesis of this protein, establishing that it is encoded by dbl. Subcellular localization studies revealed that p66 is a cytoplasmic protein distributed between cytosol and crude membrane fractions. Moreover, p66 was shown to be a phosphoprotein, with phosphorylation specific to serine residues. Our characterization of the dbl-encoded protein appears to distinguish this transforming gene product from those of other known oncogenes. 相似文献
53.
54.
Devang N Patel Francis D Pagani Todd M Koelling David B Dyke Ragavendra R Baliga Robert J Cody Kathleen D Lake Keith D Aaronson 《The Journal of heart and lung transplantation》2002,21(2):204-210
BACKGROUND: Pravastatin and simvastatin prolong survival and reduce transplant-related coronary vasculopathy, although low-density lipoprotein (LDL) lowering with these agents is only modest. The objective of this study was to assess the safety of moderate dose atorvastatin and its efficacy when prior treatment with another statin had failed to lower LDL to < 100 mg/dl. METHODS: Data from 185 patients were retrospectively evaluated for adverse events, duration of exposure (person-days), and the mean atorvastatin dose exposure. Changes in lipid parameters, and prednisone and cyclosporine doses were determined. RESULTS: Safety: 48 patients received atorvastatin for 24,240 person-days at a mean dose exposure of 21 +/- 10 mg. Rhabdomyolysis, myositis, myalgias, and hepatotoxicity occurred in 0, 2, 2, and 0 patients, respectively. All events occurred at the 10-mg dose, within the first 3 months, and were rapidly reversible with atorvastatin discontinuation. Efficacy: Thirty-four patients evaluable for efficacy analyses had a pre-atorvastatin LDL of 145 +/- 38 mg/dl on the following statins: pravastatin (n = 30, 40 +/- 0mg), fluvastatin (n = 3, 33 +/- 12 mg), simvastatin (n = 1, 40 mg). After atorvastatin (21 +/- 9 mg/day) for 133 +/- 67 days, LDL was reduced to 97 +/- 24 mg/dl (relative reduction 31 +/- 20%, p < 0.0001). At the end of the observation period (418 +/- 229 days, atorvastatin final dose 24 +/- 14 mg/day), LDL was further decreased to 88 +/- 23 mg (relative reduction 37 +/- 17%, p < 0.0001). CONCLUSION: Atorvastatin, when used at moderate doses and with close biochemical and clinical monitoring, appears to be safe and is effective in aggressively lowering LDL in heart transplant recipients when treatment with other statins has failed to achieve LDL goals. 相似文献
55.
Neil M. Rofsky Donald J. Pizzarello Jeffrey C. Weinreb Michael M. Ambrosino Carl Rosenberg 《Journal of magnetic resonance imaging : JMRI》1994,4(6):805-807
Pregnant mice were exposed to one of five regimens at 9.5 days of gestation: no treatment (group 1), intraperitoneal injection of normal saline (group 2), intraperitoneal injection of gadopentetate dimeglumine (group 3), intraperitoneal injection of gadopentetate dimeglumine and magnetic resonance (MR) exposure (group 4), and MR exposure alone (group 5). At 18 days of gestation, the mice were sacrifice and fetuses were removed and examined for the following end points: litter size, number alive or dead, fetal weight, extremity morphology, eye and ear development, and appearance of the head. A total of 739 fetuses were analyzed: group 1 (n = 161), group 2 (n = 149), group 3 (n = 142), group 4 (n = 136), and group 5 (n = 151). The only statistically significant difference was a lower mean fetal weight in the saline-injection group compared with the control group. The results show that MR exposure with and without gadopentetate dimeglumine had no adverse effect on the end points analyzed. 相似文献
56.
Stephen R. Kisely Mike Wise Neil Preston Senia Malmgren Peter Shannon 《Australian and New Zealand journal of public health》2003,27(3):261-263
Objectives: To evaluate a group intervention to help individuals with psychiatric disorder stop smoking.
Method: A waitlist-treatment crossover design. Outcome measures included smoking cessation, motivation to stop, the Fagerstrom Test for Nicotine Dependence (FTND), urinary cotinine and psychiatric symptoms on the General Health Questionnaire.
Results: 38 subjects participated, of whom 19 completed the waitlist and intervention phases. There were no significant differences between subjects and dropouts. During the waitlist period there were no significant changes in tobacco use. At the end of the intervention, almost a quarter had stopped smoking, ( z = -2.24, p =0.02). Subjects also showed significant improvements on state of change, FTND score and urinary cotinine levels. These improvements were maintained at three-month follow-up (n=10). Psychiatric morbidity showed no change.
Conclusions: It is possible to reduce smoking in individuals with psychiatric disorder.
Implications: Larger randomised controlled trials are indicated to determine the relative contributions of nicotine replacement, bupropion and group interventions to smoking cessation in this population. 相似文献
Method: A waitlist-treatment crossover design. Outcome measures included smoking cessation, motivation to stop, the Fagerstrom Test for Nicotine Dependence (FTND), urinary cotinine and psychiatric symptoms on the General Health Questionnaire.
Results: 38 subjects participated, of whom 19 completed the waitlist and intervention phases. There were no significant differences between subjects and dropouts. During the waitlist period there were no significant changes in tobacco use. At the end of the intervention, almost a quarter had stopped smoking, ( z = -2.24, p =0.02). Subjects also showed significant improvements on state of change, FTND score and urinary cotinine levels. These improvements were maintained at three-month follow-up (n=10). Psychiatric morbidity showed no change.
Conclusions: It is possible to reduce smoking in individuals with psychiatric disorder.
Implications: Larger randomised controlled trials are indicated to determine the relative contributions of nicotine replacement, bupropion and group interventions to smoking cessation in this population. 相似文献
57.
Jonathan Cook Neil Prose Mitchell Heflin 《Dermatologic surgery》2003,29(9):1994; author reply 1994-1994; author reply 1995
58.
Yasser Samman Imran Masood Vijay Vardhan Killampalli Neil Howell E. Kaya Alpar Sunil K. Banerjee 《European Journal of Trauma》2005,31(2):133-137
Background and Purpose:
Management of rib fractures constitutes a major part of the trauma workload of any unit. Rib fractures result in disrupted chest wall mechanics and ventilatory insufficiency. The ability of a lung injury scoring system to predict the degree of respiratory dysfunction after rib fractures was evaluated. 相似文献59.
Alister Oliver Mark Wright Andrew Matson Graham Woodrow Neil King Louise Dye 《Nephrology, dialysis, transplantation》2004,19(11):2883-2885
BACKGROUND: Interdialytic weight gain (IDWG) can be reduced by lowering the dialysate sodium concentration ([Na]) in haemodialysis patients. It has been assumed that this is because thirst is reduced, although this has been difficult to prove. We compared thirst patterns in stable haemodialysis patients with high and low IDWG using a novel technique and compared the effect of low sodium dialysis (LSD) with normal sodium dialysis (NSD). METHODS: Eight patients with initial high IDWG and seven with low IDWG completed hourly visual analogue ratings of thirst using a modified palmtop computer during the dialysis day and the interdialytic day. The dialysate [Na] was progressively reduced by up to 5 mmol/l over five treatments. Dialysis continued at the lowest attained [Na] for 2 weeks and the measurements were repeated. The dialysate [Na] then returned to baseline and the process was repeated. RESULTS: Baseline interdialytic day mean thirst was higher than the dialysis day mean for the high IDWG group (49.9+/-14.0 vs 36.2+/-16.6) and higher than the low weight gain group (49.9+/-14.0 vs 34.1+/-14.6). This trend persisted on LSD, but there was a pronounced increase in post-dialysis thirst scores for both groups (high IDWG: 46+/-13 vs 30+/-21; low IDWG: 48+/-24 vs 33+/-18). The high IDWG group demonstrated lower IDWG during LSD than NSD (2.23+/-0.98 vs 2.86+/-0.38 kg; P<0.05). CONCLUSIONS: Our results indicate that patients with high IDWG experience more intense feelings of thirst on the interdialytic day. LSD reduces their IDWG, but paradoxically increases thirst in the immediate post-dialysis period. 相似文献
60.
Neil Andersson 《AIDS research and therapy》2006,3(1):23-3
With the exception of post-exposure prophylaxis for reported rape, no preventive strategy addresses the choice disabled –
those who might like to benefit from AIDS prevention but who are unable to do so because they do not have the power to make
and to act on prevention decisions. In southern African countries, where one in every three has been forced to have sex by
the age of 18 years, a very large proportion of the population is choice disabled. This group is at higher risk of HIV infection
and unable to respond to AIDS prevention programmes; they represent a reservoir of infection. Reduction of sexual violence
would probably decrease HIV transmission directly, but also indirectly as more people can respond to existing AIDS prevention
programmes. 相似文献